Pathway raises C$5m in Yamaha Motor Ventures-led seed deal

• The round was led by Yamaha Motor Ventures, joined by Verge HealthTech Fund
• Other participants were existing investors, among them Amplify Capital, BoxOne Ventures and Formentera Capital, as well as several physicians
• Founded in 2020, Pathway distills practice guidance from millions of evidence-based sources into concise summaries for clinicians

Pathway, a Montreal-based artificial intelligence (AI)-enabled medical knowledge platform, has secured C$5 million in seed financing.

The round was led by Yamaha Motor Ventures, joined by Verge HealthTech Fund. Other participants were existing investors, among them Amplify Capital, BoxOne Ventures and Formentera Capital, as well as several physicians.

Founded in 2020, Pathway distills practice guidance from millions of evidence-based sources into concise summaries, helping clinicians stay up-to-date and provide efficient, high-quality care. It has a growing community of more than 350,000 verified clinicians from a range of institutions.

The funds raised will allow Pathway to continue to improve its technology.

“Pathway is quickly establishing itself as the go-to resource for healthcare professionals who need fast, evidence-based answers to their everyday questions. We and our investors share a vision to transform how medical knowledge is organized and delivered through the power of AI,” said Jonathan Hershon, CEO of Pathway, in a statement. “This funding will accelerate the rollout of Pathway’s technology and amplify our reach to clinicians globally.”

Pathway announced it is making its clinical decision support tool open access. It also unveiled Pathway AI, an advanced AI assistant and search tool, in limited beta.